Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

iNanoBIT · Integration of Nano- and Biotechnology for beta-cell and islet Transplantation

H2020Status: CLOSED1 October 201731 March 2023EU funding €6,999,998Call H2020-NMBP-2016-2017

The iNanoBIT project is aimed to apply nanotechnologies for imaging porcine pancreatic islet cellular transplants and induced pluripotent stem cell-derived beta-cells and subsequent regenerative processes in vivo in a porcine model. The project will develop1) novel highly sensitive nanotechnology-based imaging approaches allowing for monitoring of survival, engraftment, proliferation, function and whole body distribution of the cellular transplants in a preclinical porcine model with excellent translational potential to humans; 2) develop and validate the application of state-of-the-art imaging technologies facilitating the provision of new regenerative therapies to preclinical large animal models and patients; 3) directly contribute to the opening of a new market sector for i) imaging equipment (SPECT, PET/MR, optoacoustic imaging in preclinical large animal models and patients), ii) nano-imaging molecule supplies (nanomolecules allowing multimodality imaging of specific cell types with high sensitivity), iii) validated transplantable in vitro differentiated human beta-cells and porcinexenotransplant islets thus will reinforce the European healthcare supply chain for regenerative medicinal products. The iNanoBIT project will provide the currently missing toolbox for preclinical/clinical testing for a safe translation of regenerative medicinal cellular and tissue products, currently under preclinical and clinical trials, which is vital for the competitiveness of the European healthcare sector in this fast-growing area. The consortium of 5 SME and 3 Academic partners is coordinated and driven by the industrial partners from the field of nanotechnology, imaging and stem cell technologies, providing a perfect match and unique combination addressing the scope and expected impact of the call and providing TRL 3/4 starting points for the key technological elements, and expect to arrive to TRL6 levels of validated technologies ready for marketing by the end of the project.

Consortium · 9 organisations

coordinator

BIOTALENTUM TUDASFEJLESZTO KFT

HU · €1,301,341

participant

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

DE · €1,629,575

participant

UNIVERSITE CATHOLIQUE DE LOUVAIN

BE · €628,750

thirdParty

ITHERA SCIENTIFIC GMBH

DE

participant

BBS NANOTECHNOLOGIA KUTATASI ES FEJLESZTESI KORLATOLT FELELOSSEGU TARSASAG

HU · €710,726

participant

DEFYMED

FR · €645,625

participant

UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

IT · €652,564

participant

Mediso Orvosi Berendezes Fejleszto es Szerviz Kft.

HU · €795,375

participant

ITHERA MEDICAL GMBH

DE · €636,041

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.